[1] SUGAWARA N,YASUI-FURUKORI N,UMEDA T,et al.Effect of age and disease on bone mass in Japanese patients with schizophrenia[J].Ann Gen Psychiatry,2012,11(1):5.
[2] JUNG D U,KELLY D L,OH M K,et al.Bone mineral density and osteoporosis risk in older patients with schizophrenia[J].J Clin Psychopharmacol,2011,31(4):406-410.
[3] DOKNIC M,MARIC N P,BRITVIC D,et al.Bone remodeling,bone mass and weight gaim in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone[J].Neuroendocrinology,2011,94(3):246-254.
[4] PARTTI K,HELIOVAARA M,IMPIVAARA O,et al.Skeletal status in psychotic disorders:a populationbased study[J].Psychosom Med,2010,72(9):933-940.
[5] RENN J H,YANG N P,CHUEH C M,et al.Bone mass in schizophrenia and normal populations across different decades of life[J].BMC Musculoskelet Disord,2009,10(1):1.
[6] REY-SANCHEZ P,LAVADO-GARCIA J M,CANAL-MACIAS M L,et al.Ultrasond bone mass in schizophrenic patients on antipsychotic therapy[J].Hum Psychopharmacol,2009,24(1):49-54.
[7] 冒雷鸣,徐健,缪海燕,等.精神分裂症与骨质疏松症的相关性研究进展[J].临床精神医学杂志,2015,25(4):277-278.
[8] 杨宏亮,王美娟,张述杰,等.氯氮平对男性精神分裂症患者骨密度的影响[J],中国医学创新,2015,12(6):130-131.
[9] 张昕,王峻,苏晋生,等.定量CT与双能X线吸收测定仪测量腰椎各椎体间骨密度差异性研究[J].中国医学影像学杂志,2011,19(12):884-886.
[10] BAASTRUP P C,CHRISTISTIANSEN C,TRANSBOL I.Calcium metabolism in schizophrenic patients on longterm neuroleptic therapy[J].Neuropsychobiology,1980,6(1):56-59.
[11] ADAMS J E.Quantitative computed tomography[J].Eur J Radiol,2009,71(3):415-424. |